| <img alt="" height="1" width="1" />Piper Jaffray Reiterates Overweight, $58 Price Target On Salix Pharmaceuticals ...BenzingaWith over $1B in peak sales potential driven largely by adoption in hepatic encephalopathy(HE) and non-constipation irritable bowel syndrome (IBS), ...<nobr>and more »</nobr> |
Google- Piper Jaffray Reiterates Overweight, $58 Price Target On Salix Pharmaceuticals ... - Benzinga
1 - 1 of 1 Posts
1 - 1 of 1 Posts
- This is an older thread, you may not receive a response, and could be reviving an old thread. Please consider creating a new thread.
Join the discussion
Irritable Bowel Syndrome and Digestive Health Support Forum
A forum community dedicated to Irritable Bowel Syndrome and Digestive Health Support. Come join the discussion about treatment, diet, health, lifestyles, spirituality, medication, research, recovery, and more!
Full Forum Listing
Recommended Communities
Join now to ask and comment!